Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Panic disorder as presenting symptoms of multiple sclerosis.
Correction: Search for Cellular Stress Biomarkers in Lymphocytes from Patients with Multiple Sclerosis: A Pilot Study.
BACH2 represses effector programs to stabilize T(reg)-mediated immune homeostasis.
Cause and prevention of demyelination in a model multiple sclerosis lesion.
Modeling the course and outcomes of MS is statistical twaddle-No.
Analysis of CH25H in multiple sclerosis and neuromyelitis optica.
Prenylated Flavonoids from Cudrania tricuspidata Suppress Lipopolysaccharide-Induced Neuroinflammatory Activities in BV2 Microglial Cells.
Therapeutic targeting of complement to modify disease course and improve outcomes in neurological conditions.
Medical, functional, and legal aspects of vocational rehabilitation for people with multiple sclerosis.
Patterns and predictors of naturally occurring change in depressive symptoms over a 30-month period in multiple sclerosis.
Bridging network divides: Building capacity to support aging with disability populations through research.
Active Cognitive Reserve Influences the Regional Atrophy to Cognition Link in Multiple Sclerosis.
Predicting falls in people with multiple sclerosis: fall history is as accurate as more complex measures.
Jacobian integration method increases the statistical power to measure gray matter atrophy in multiple sclerosis.
Motor cortex rTMS improves dexterity in relapsing-remitting and secondary progressive multiple sclerosis.
Low dose cyclophosphamide effectively mobilizes peripheral blood stem cells in patients with autoimmune disease.
Risk Mitigation Strategies for Adverse Reactions Associated with the Disease-Modifying Drugs in Multiple Sclerosis.
Characteristics of Patients With Relapsing Remitting Multiple Sclerosis (Rrms) Taking Injectable and Oral Disease Modifying Treatments (Dmt) In Europe (Eu).
Loss of Mobility and the Patient Burden of Multiple Sclerosis: Expert Opinion on Relevance to Daily Clinical Practice.
The BDNF val(66)met polymorphism has opposite effects on memory circuits of multiple sclerosis patients and controls.
Risk factors for multiple sclerosis, neuromyelitis optica and transverse myelitis.
Severe exacerbation of psoriasis after intravenous immunoglobulin in patient with multiple sclerosis that started during biologic therapy.
[Immunotherapies for multiple sclerosis : Review and update.]
Cuprizone-induced demyelination and demyelination-associated inflammation result in different proton magnetic resonance metabolite spectra.
Blocking GluR2-GAPDH ameliorates experimental autoimmune encephalomyelitis.

Pages